tiprankstipranks
Athira Pharma (ATHA)
NASDAQ:ATHA
US Market

Athira Pharma (ATHA) Income Statement

Compare
553 Followers

Athira Pharma Income Statement

Last quarter (Q3 2024), Athira Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Athira Pharma's net income was $-28.74M. See Athira Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -969.00K$ -1.05M$ -479.00K$ -2.00M$ 0.00
Operating Expenses
$ 125.47M$ 88.86M$ 55.19M$ 18.67M$ 4.70M
Depreciation and Amortization
$ 969.00K$ 1.05M$ 479.00K$ 2.00M$ 2.00K
EBITDA
$ -116.70M$ -94.59M$ -54.37M$ -19.01M$ -4.82M
Operating Income
$ -125.47M$ -104.02M$ -64.02M$ -20.00M$ -5.45M
Other Income/Expenses
$ 7.79M$ 8.38M$ 9.17M$ 40.00K$ 288.00K
Pretax Income
$ -117.67M$ -95.64M$ -54.85M$ -19.95M$ -5.16M
Net Income
$ -117.67M$ -87.26M$ -54.37M$ -18.63M$ -4.70M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.10$ -2.31$ -1.47$ -0.57$ -0.14
Diluted EPS
$ -3.09$ -2.31$ -1.47$ -0.57$ -0.14
Weighted Average Shares Outstanding
38.02M 37.73M 36.92M 32.49M 32.62M
Weighted Average Shares Outstanding (Diluted)
38.02M 37.73M 36.92M 32.49M 32.62M
Currency in USD

Athira Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis